Barclays
XRAY icon

Barclays’s Dentsply Sirona XRAY Stock Holding History

Barclays’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,700
Closed -$606K – 6511
2019
Q4 		$606K Hold
10,700
– – ﹤0.01% 4124
2019
Q3 		$570K Buy
+10,700
New +$575K ﹤0.01% 4140
2018
Q4 		– Sell
-600
Closed -$23K – 7393
2018
Q3 		$23K Buy
+600
New +$25K ﹤0.01% 6431
2018
Q1 		– Sell
-40,400
Closed -$2.66M – 7373
2017
Q4 		$2.66M Buy
40,400
+400
+1% +$25.4K ﹤0.01% 2181
2017
Q3 		$2.39M Buy
+40,000
New +$2.38M ﹤0.01% 2161
2015
Q4 		– Sell
-900
Closed -$45K – 6661
2015
Q3 		$45K Buy
+900
New +$47.9K ﹤0.01% 5070
2015
Q2 		– Sell
-2,100
Closed -$105K – 7236
2015
Q1 		$105K Sell
2,100
-3,300
-61% -$170K ﹤0.01% 4823
2014
Q4 		$286K Buy
5,400
+200
+4% +$10.2K ﹤0.01% 4354
2014
Q3 		$234K Sell
5,200
-2,900
-36% -$136K ﹤0.01% 4608
2014
Q2 		$381K Sell
8,100
-13,400
-62% -$623K ﹤0.01% 4235
2014
Q1 		$989K Buy
21,500
+4,800
+29% +$222K ﹤0.01% 3248
2013
Q4 		$801K Buy
16,700
+16,500
+8,250% +$772K ﹤0.01% 3625
2013
Q3 		$9K Sell
200
-100
-33% -$4.27K ﹤0.01% 6828
2013
Q2 		$12K Buy
+300
New +$12.5K ﹤0.01% 7064

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Barclays's XRAY Position: Q1 2026 in Review

Barclays reduced its Dentsply Sirona (XRAY) stake by 1.6% in Q1 2026, selling an estimated $28.4K and leaving 138,911 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Barclays first reported a position in XRAY in Q2 2013 and has held it in 52 quarters since. The position peaked at $25M in Q1 2018. 384 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Barclays held 138,911 shares of Dentsply Sirona worth $1.61M as of Q1 2026.
  • Barclays sold 2,277 Dentsply Sirona shares in Q1 2026, an estimated $28.4K.
  • Dentsply Sirona made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2494 holding.
  • Barclays first reported a position in Dentsply Sirona in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Dentsply Sirona position peaked at $25M in Q1 2018.
  • 384 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.